Issues in the neuromodulation market.
Neuromodulation devices currently available have two screaming issues. Our device solves both of these.
Imprecision.
Everyone's brain is different. Patient specific AI powered closed-loop stimulation is the future we are building.
Extremely high costs
The average neuromodulation system costs over £25,000. This makes neurmodulation therapy inaccessible for many, leading to pain, suffering, and worsening symptoms.
In contrast, our device will offer a tissue-targeting accuracy that is 10x more precise, while costing almost 100x less.
No other at-home neuromodulation device offers this combination of sub-millimeter accuracy and affordability.
To understand the scale of this issue, 1 in 3 people will experience anxiety, depression, or cognitive fatigue in their lifetime.
That is 2.7 billion people worldwide! This shows the huge issue presented, yet it also provides an incredibly promising customer base.